GENITOURINARY CANCER
Clinical trials for GENITOURINARY CANCER explained in plain language.
Never miss a new study
Get alerted when new GENITOURINARY CANCER trials appear
Sign up with your email to follow new studies for GENITOURINARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare genitourinary cancers
Disease control OngoingThis study tests a combination of two immunotherapy drugs, nivolumab and ipilimumab, in about 100 adults with rare genitourinary cancers (like adrenal, penile, or bladder cancers). The goal is to see if the drugs can shrink tumors and control the disease. This is not a cure; pati…
Matched conditions: GENITOURINARY CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Engineered immune cells and vaccine take aim at Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a treatment for adults with certain advanced solid tumors (like colorectal, lung, or breast cancer) that have spread and stopped responding to standard therapy. The approach uses a person's own white blood cells, which are genetically modified in a la…
Matched conditions: GENITOURINARY CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New program helps cancer patients and caregivers talk through tough emotions
Symptom relief OngoingThis study tests a program that helps cancer patients and their caregivers manage difficult emotions and communicate better about the illness. It includes a version tailored for Latinx participants. The goal is to reduce distress, improve quality of life, and help families discus…
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
Tumor profiling study aims to personalize cancer care
Knowledge-focused OngoingThis study collects tumor samples from over 3,000 adults with advanced cancers to look for specific genetic markers, called biomarkers. The goal is to help doctors choose the most promising targeted therapy or clinical trial for each patient. Participants do not receive a new tre…
Matched conditions: GENITOURINARY CANCER
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 17, 2026 00:49 UTC
-
Biopsy study aims to match advanced cancer patients with best treatments
Knowledge-focused OngoingThis study collects tissue and blood samples from 156 people with advanced prostate, kidney, or bladder cancers. Researchers analyze these samples to find genetic markers that predict how well different treatments work. Participants undergo a biopsy of a growing tumor before star…
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New breathing method tested in robotic cancer surgeries
Knowledge-focused TerminatedThis pilot study tests a different way of using a breathing machine (APRV) during anesthesia for robotic gynecologic or genitourinary cancer surgery, comparing it to the standard method (CMV). The goal is to see if APRV improves lung function during the operation. Twelve adult ca…
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC